BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Lagos
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0100
TZNAME:WAT
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211104
DTSTAMP:20210930T162552Z
CREATED:20210930T162552Z
LAST-MODIFIED:20210930T162552Z
UID:49950-1635724800-1635983999@globalbiodefense.com
SUMMARY:Africa CDC Inaugural One Health Conference
DESCRIPTION:The Africa CDC Inaugural One Health Conference taking place virtually from 1 – 3 November 2021. \nOne Health is a collaborative\, multisectoral and transdisciplinary approach used to attain optimal health outcomes for people\, animals\, plants\, and their shared environment. Practically\, One Health involves the collaboration between human\, animal\, and environmental health sectors as well as other relevant stakeholders\, in the design and implementation of programmes\, policies\, legislation\, and research intended to achieve better health outcomes for all. \nTo celebrate and share the various One Health work taking place on the continent\, the Africa Centres for Disease Control and Prevention (Africa CDC) is hosting a 3-day virtual One Health Conference from 1-3 November 2021. The conference aims to: \n\nShare best practices and experiences from Member States and partners.\nShowcase continental One Health research focusing on zoonotic disease surveillance and outbreak investigations\, antimicrobial resistance\, food safety\, environmental health\, and operational research through scientific presentations.\nHighlight operational tools and guidance documents developed by African Union organs and technical partners like WHO\, OIE and FAO.\nExhibit opportunities for collaboration or One Health implementation support.\nStrengthen One Health advocacy and capacity across the AU Member States and Regional networks.\n\nPresenters will include representatives from Africa Union Member States\, RECs\, Africa Union technical agencies\, Africa CDC RCCs\, research institutions and technical partners. \nThis conference is hosted by Africa CDC in association with SBS Conferences & Exhibitions. \nQueries may be directed to info@sbs.co.za or +27 (0)71 348 1780. Registration is FREE and open to anyone interested in or involved in the field of One Health on the African continent. \nPlease visit the Africa CDC Inaugural One Health Conference website for more information. \n 
URL:https://globalbiodefense.com/event/africa-cdc-inaugural-one-health-conference/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/09/africa-cdc-one-health-conference.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211105
DTSTAMP:20210924T232710Z
CREATED:20210924T232546Z
LAST-MODIFIED:20210924T232710Z
UID:49795-1635724800-1636070399@globalbiodefense.com
SUMMARY:Eighth Arab-American Frontiers of Science\, Engineering\, and Medicine Symposium
DESCRIPTION:The Arab-American Frontiers program brings together outstanding young scientists\, engineers\, and medical professionals from the United States and the 22 countries of the Arab League for a series of symposia to discuss exciting advances and opportunities in their fields. \nDue to ongoing concerns surrounding the new COVID-19 variant\, the Eighth Symposium will now take place online\, November 1-4\, 2021. \nThe goal of these meetings is to enhance the scientific exchange and dialogue among young researchers in Arab countries and the United States\, including the Arab science diaspora\, and through this interaction\, facilitate research collaboration within and beyond the region. \nThe eighth symposium will discuss advances across a broad range of multi-disciplinary topics through five plenary sessions. These sessions are: \n\nSession I: Advanced Materials\nSession II: e-Health\nSession III: Water\, Food\, Environment\nSession IV: Cybersecurity\nSession V: Emerging Technologies and Society\n\nHighlighted topics include: \n\nApplying Patient and Public Health Data for Pandemic Response and Health Security (TBC)\nFrom Drones to Dentures: How Novel Materials are Increasing the Adoption of 3d Printing Across Every Industry\nApplications of Smart Wearable Devices in Health: Data\, Policy\, and Security Considerations\n\nThis symposium is made possible by the generous support of USAID\, Hamad bin Khalifa University\, and the National Science Foundation.
URL:https://globalbiodefense.com/event/eighth-arab-american-frontiers-of-science-engineering-and-medicine-symposium/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211103
DTEND;VALUE=DATE:20211105
DTSTAMP:20210812T192722Z
CREATED:20210812T192722Z
LAST-MODIFIED:20210812T192722Z
UID:49489-1635897600-1636070399@globalbiodefense.com
SUMMARY:BARDA Industry Day 2021 – BID2021
DESCRIPTION:This BARDA Industry Day 2021 Virtual Event will be held 3-4 November 2021. \nThis annual gathering of more than 1300 stakeholders from the public and private sector provides an opportunity to increase understanding of the U.S. government medical countermeasure priorities and funding goals; interact with BARDA and ASPR staff; and showcase innovations. \nInnovators may apply for limited openings to present during Lightning Talks sessions. Lightning Talks are for individuals\, academic institutions\, pharmaceutical companies\, biotech\, and other industry innovators to showcase their innovative technologies. \nTo submit your application for the Lightning Talks\, please enter the requested information and provide a brief (maximum 500 words) summary of your proposed presentation\, with one optional PowerPoint slide\, by 16 August. \nVisit the BARDA Industry Day website for more information. \n  \n 
URL:https://globalbiodefense.com/event/barda-industry-day-2021-bid2021/
CATEGORIES:Conference,Government Hosted,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/08/bid-2021-barda-industry-day.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20211014T233809Z
CREATED:20211014T233450Z
LAST-MODIFIED:20211014T233809Z
UID:50256-1635984000-1636156799@globalbiodefense.com
SUMMARY:NIH 2021 Synthetic Biology Consortium
DESCRIPTION:The 2021 Annual Synthetic Biology Consortium Meeting will take place in virtual format from November 4-5\, 2021. \nThe 2021 Synthetic Biology Consortium Meeting will facilitate networking and collaboration among synthetic biology investigators. Attendees can use this meeting to collaborate with each other on current topics in synthetic biology and engage with NIH program directors. \nHighlighted presenters and panelists include: \n\nKaren Elkins\, FDA\, Center for Biologics Evaluation and Research\nMichelle Bond\, NIGMS\, Division of Pharmacology\, Physiology\, and Biological Chemistry\nTuba Fehr\, NICHD\, Development Biology and Structural Variation Branch\nTim Lu\, Massachusetts Institute of Technology\nGary Lee\, Senti Biosciences\nStephanie Morris\, NHGRI\, Division of Genome Sciences\nBrigitte Sanders\, NIAID\, Division of AIDS\nHye-Sook Kim\, NCCIH\, Basic and Mechanistic Research\nTatjana Atanasijevic\, NIBIB\, Division of Applied Science and Technology (Bioimaging)\nParijat Bhatnagar\, SRI International\nJoshua Leonard\, Northwestern University\nTara Deans\, The University of Utah\nDave Rampulla\, NIBIB\, Division of Discovery Science and Technology (Bioengineering)\nRahul Thakar\, NHLBI\, Advanced Technologies and Surgery Branch\nRyan Richardson\, NINDS\, Office of the BRAIN Director\nJerry Li\, NCI\, Structural Biology and Molecular Applications Branch\nKelly Crotty\, NCI\, Center for Strategic Scientific Initiatives\nJiahe Li\, Northeastern University\nTal Danino\, Columbia University\nAndrew Ellington\, University of Texas at Austin\nOphelia Venturelli\, University of Wisconsin-Madison\n\nPlease visit NIH’s 2021 Synthetic Biology Consortium meeting site for more information. \n 
URL:https://globalbiodefense.com/event/nih-2021-synthetic-biology-consortium/
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
LOCATION:https://www.zoomgov.com/meeting/register/vJItfu-hpzIiHqmy-7yogDu9ImlF2Lfd0iE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211105T090000
DTEND;TZID=America/New_York:20211105T101500
DTSTAMP:20211004T004515Z
CREATED:20211004T004515Z
LAST-MODIFIED:20211004T004515Z
UID:50031-1636102800-1636107300@globalbiodefense.com
SUMMARY:Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations
DESCRIPTION:The Center for Global Development will host an online event on Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations on 5 Nov 2021. \nSince the early days of the COVID-19 pandemic\, many institutes have been using epidemiological modelling to predict the spread of the novel coronavirus as well as estimate the impact of different control measures. \nWith the development of multiple vaccine candidates\, new questions have now arisen as to how policymakers can ensure cost-effective COVID-19 vaccine deployment and allocation that considers both operational constraints (e.g.\, in-country cold chain or human resources for healthcare capacity) and epidemiological characteristics (e.g.\, seroprevalence\, social mixing\, age-stratification\, comorbidities\, vaccine stretching etc). \nIn this event\, study groups will present and disseminate results that tackle a diverse range of research questions focusing on COVID19 vaccine deployment and allocation. A wider discussion will follow focussing on how decision makers can consider epidemiological and operational modelling evidence to inform cost-effective COVID-19 vaccine deployment and allocation and highlight potential future steps and generalisable lessons for many lower resource settings. \nPRESENTERS \n\nNimalan Arinaminpathy\, Professor in Mathematical Epidemiology\, Imperial College London\nSarang Deo\, Professor\, Indian School of Business\nSripad Devalkar\, Associate Professor of Operations Management\, Indian School of Business\n\nPlease visit the Allocating Scarce COVID-19 Vaccines Based on Epidemiological and Operational Considerations event site to register.
URL:https://globalbiodefense.com/event/allocating-scarce-covid-19-vaccines-based-on-epidemiological-and-operational-considerations/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://www.youtube.com/watch?v=fBrn7Ayos2U
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211108T120000
DTEND;TZID=America/New_York:20211108T150000
DTSTAMP:20210925T002112Z
CREATED:20210925T002112Z
LAST-MODIFIED:20210925T002112Z
UID:49797-1636372800-1636383600@globalbiodefense.com
SUMMARY:Impact of and Response to the Pandemic: Webinar 1
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/impact-of-and-response-to-the-pandemic-webinar-1/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211111
DTEND;VALUE=DATE:20211114
DTSTAMP:20210226T211932Z
CREATED:20210226T211804Z
LAST-MODIFIED:20210226T211932Z
UID:48685-1636588800-1636847999@globalbiodefense.com
SUMMARY:APCCMI 2021 - Asia Pacific Congress of Clinical Microbiology and Infection
DESCRIPTION:The APCCMI 2021 Asia Pacific Congress of Clinical Microbiology and Infection will take place 11-13 November 2021 in Singapore and through virtual offerings. \nAPCCMI is the biennial conference for the Asia Pacific Society of Clinical Microbiology and Infection (APSCMI). \nHighlighted topics include: \n\nMERS CoV\, avian influenza and other respiratory viruses\nTransplant infectious diseases\nAdvances in rapid diagnostics\nAdvances in influenza therapeutics\nOne Health in infectious diseases\nMalaria and vector borne infections\nHot topics in antimicrobial stewardship\nTuberculosis and mycobacteria\nUtility of genome sequencing\nClinical implications of microbiome\n\nWho should attend? \nInfectious disease doctors\, trainees and scientists\nClinical and laboratory microbiologists\nInfection control professionals including doctors\, nurses and epidemiologists\nOutbreak control professionals including doctors\, epidemiologists and policy makers\nPharmacists and pharmacologists\nScientists and students undertaking research in the related fields\nVaccine professionals including doctors\, nurses\, pharmacists and policy makers \nPlease visit the APCCMI 2021 website for more information.
URL:https://globalbiodefense.com/event/apccmi-2021-asia-pacific-congress-of-clinical-microbiology-and-infection/
LOCATION:Suntec Singapore Convention Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211112T083000
DTEND;TZID=America/New_York:20211112T133000
DTSTAMP:20211111T190139Z
CREATED:20211101T175106Z
LAST-MODIFIED:20211111T190139Z
UID:50918-1636705800-1636723800@globalbiodefense.com
SUMMARY:The Future of Malaria Research Symposium
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12\, prior to the American Society of Tropical Medicine and Hygiene’s annual meeting. \nStudents\, postdoctoral researchers\, and early career scientists are encouraged to submit an abstract to be considered for a short or long talk. Dr. Etienne Bilgo\, Postdoctoral Fellow in Biomedical Sciences at the Institut de Recherche en Science de la Santé-IRSS/Centre Muraz will deliver the keynote address. Organized by postdocs and students\, the event will be held via Zoom and scientists at all career levels are encouraged to attend. \nHighlighted topics include: \n\nVectorCAM: a low cost hand held tool for automated\, rapid morphological identification of mosquito species\nIdentification of a novel determinant associated with quinine resistance in a Plasmodium falciparum genetic cross\nModeling the emergence of piperaquine-resistant Plasmodium falciparum malaria in Africa\nMitochondrial multidrug resistant transporter (MDR6) and its interaction with the ISC pathway in Plasmodium falciparum\nInappropriate sales of antimalarials in private-sector drug shops in rural Uganda\nA modular cloning system for high efficiency production of Plasmodium falciparum transfection vectors\nEvaluating the effects of sorbitol synchronization of clinical isolates of Plasmodium falciparum on their susceptibility to antimalarial compounds\nComparison of overnight to early evening malaria vector collections in indoor setting in Nchelenge District\, Zambia\nNovel kinases play an essential role during asexual proliferation of Plasmodium falciparum parasites”\nImpacts of a 4.3kb structural variant on gene expression and insecticide resistance phenotype in the malaria vector An. funestus s.s.\nFactors associated with asymptomatic recurrences due to Plasmodium vivax infection after radical cure treatment in communities in the Peruvian Amazon\nOctopi: a ready-to-deploy high-throughput imaging solution for malaria management and malaria research\nDistinct antibody responses to Plasmodium antigens reveal candidate biomarkers of the intensity and timing of past exposure to malaria\nAn ex vivo model of oxidatively stressed red blood cells demonstrates a role for exogenous amino acids in enhancing bystander red blood cell function and morphology in malaria\nSystems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria\nA Male-Drive Female-Sterile (MDFS) system in Anopheles gambiae targeting doublesex\nAssessing the use of microRNAs for the diagnosis of severe falciparum malaria\nPrevalence of Plasmodium falciparum submicroscopic infection and pregnancy outcomes in Congolese women at delivery\nUsing transgenic fungi to kill malaria mosquitoes\nConditional knockdown of essential proteins in P. falciparum Midgut Stages\nA semi-field system for quantitative tracking of Anopheles gambiae olfactory preferences\nEstimating the impact of RTS\,S deployment in areas with seasonal malaria chemoprevention\nTrends in falciparum malaria prevalence\, parasite density and associated risk factors in Akure\, Southwestern Nigeria: An implication for malaria elimination\nAssessing off-target effects of CRISPR-Cas9 based gene drives in Anopheles gambiae\nHeritable cultivable bacteria associated to wild Anopheles gambiae s.l. in Burkina Faso for paratransgenic control perspectives of malaria\n\nPlease visit the Johns Hopkins Bloomberg School of Public Health 7th Future of Malaria Research Symposium website for more information.
URL:https://globalbiodefense.com/event/the-future-of-malaria-research-symposium/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211118
DTSTAMP:20211111T211702Z
CREATED:20211101T201407Z
LAST-MODIFIED:20211111T211702Z
UID:50931-1637020800-1637193599@globalbiodefense.com
SUMMARY:Developing a Long-Term Strategy for Low-Dose Radiation Research in the U.S.
DESCRIPTION:This meeting hosted by the National Academies will focus on receiving information from the research community on low dose radiation research priorities and lessons to be learned from managing multidisciplinary programs. \n\nWhat are your views on research priorities for low dose radiation research?\nHow can epidemiology contribute to further understanding risks?\nMolecular approaches to improve understanding of DNA repair following low dose radiation exposures\nAdvancements in dosimetry to support radiation epidemiology\nEpigenetic changes and their applications to radiation epidemiology\nClonal hematopoiesis and space radiation\nTechniques used to identify functional elements of the microbiome\nOpportunities and challenges for epigenetics and microbiome research in low dose radiation exposures\nOverview of studies of in utero exposure to radiation with emphasis on low doses\nLimitations of low-dose epidemiological studies\nModeling radiation effects including radiation carcinogenesis\, normal tissue complications\, radioresistance and non-targeted effect\nMethods and tools to estimate radiation dose in low dose radiation studies of medical\, occupational\, and environmental exposures\nMethods to study immune response and its role in cancer development and treatment\nModern techniques for mapping cells carrying mutations in normal tissues\n\nPlease visit NASEM’s Developing a Long-Term Strategy for Low-Dose Radiation Research in the United States: Meeting 6\, November 16-17\, 2021 website for more information.
URL:https://globalbiodefense.com/event/developing-a-long-term-strategy-for-low-dose-radiation-research-in-the-u-s-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T090000
DTEND;TZID=America/New_York:20211116T160000
DTSTAMP:20211111T192222Z
CREATED:20211104T181912Z
LAST-MODIFIED:20211111T192222Z
UID:50927-1637053200-1637078400@globalbiodefense.com
SUMMARY:Enhanced Drug Distribution Security at the Package Level
DESCRIPTION:The FDA will hold a virtual public meeting on November 16\, 2021\, on enhanced drug distribution security at the package level. \nThe purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug distribution security provisions of the Drug Supply Chain Security Act (DSCSA) that go into effect in 2023. \nFDA requests that stakeholders prepare comments responding to the following questions for one or more of the topics listed below: \n\nHow is implementation of the 2023 enhanced system requirements progressing for your organization?\nWhat challenges is your organization facing?\nAre the proposed recommendations in FDA’s guidance on enhanced drug distribution security at the package level helpful to achieve compliance with 2023 enhanced system requirements? If not\, what additional information would be useful?\nAre there areas in which FDA could provide more clarity?\n\nTopics\n\nEnhanced Drug Distribution Security\n\nSystem Attributes\nAggregation\, Inference\, and Physical Security Features\n\n\nSystem Structure\n\nData Architecture\nAdoption of Data and System Security\nProtecting Confidential Commercial Information and Trade Secrets\nSystem Access and Data Retrieval\n\n\nEnhanced Product Tracing\n\nSerialized Transaction Information and Data Exchange (Incorporation of the Product Identifier into Product Tracing Information)\nResponsibilities of the Selling and Buying Trading Partners with regard to the Product Tracing Information\nHandling Aggregation Errors and Other Discrepancies\n\n\nGathering of Relevant Product Tracing Information\nEnhanced Verification\n\nVerification of Distributed Product\nVerification of Saleable Return Product\nAlerts for Illegitimate Product\n\n\nTrading Partner Readiness\n\nYour organization’s overall readiness for implementation\nComponents that your organization is furthest along in developing\, including the components being prioritized and the components that are easier or more challenging to implement\n\n\n\nAdditional Information\n\nEnhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act Draft Guidance for Industry\nFDA Webinar on October 5\, 2021: Enhanced Drug Distribution Security in 2023 Under the DSCSA
URL:https://globalbiodefense.com/event/enhanced-drug-distribution-security-at-the-package-level/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211117
DTEND;VALUE=DATE:20211122
DTSTAMP:20211111T191055Z
CREATED:20211102T180552Z
LAST-MODIFIED:20211111T191055Z
UID:50922-1637107200-1637539199@globalbiodefense.com
SUMMARY:ASTMH 2021 Annual Meeting
DESCRIPTION:The American Society for Tropical Medicine and Hygiene (ASTMH) will gather virtually from 17-21 November for the Annual Meeting of leaders and scientific experts invested in tropical medicine and global health. \nThe virtual gathering will feature a wide range of COVID-19 related work\, including reports on the potential protective effects of malaria\, new vaccine innovations and how pandemic safeguards have turned fevers into a dangerous stigma. Researchers also will present new findings on elimination efforts for a number of diseases\, such as leprosy and river blindness; probe whether a smartphone app can reveal a link between pandemic outdoor time and risks of tick-borne disease; and discuss potentially promising news on tamping down resurgent malaria\, including vaccine advances and progress against insecticide resistance. \nPlease visit the ASTMH 2021 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/astmh-2021-annual-meeting/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211118T120000
DTEND;TZID=America/New_York:20211118T150000
DTSTAMP:20210925T002459Z
CREATED:20210925T002459Z
LAST-MODIFIED:20210925T002459Z
UID:49800-1637236800-1637247600@globalbiodefense.com
SUMMARY:Recovery and Resilience: Webinar 2
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/recovery-and-resilience-webinar-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T090000
DTEND;TZID=America/New_York:20211130T170000
DTSTAMP:20211111T191610Z
CREATED:20211111T191610Z
LAST-MODIFIED:20211111T191610Z
UID:50925-1638262800-1638291600@globalbiodefense.com
SUMMARY:Antimicrobial Drugs Advisory Committee (AMDAC) Meeting
DESCRIPTION:The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. \nFDA intends to make background material available to the public no later than two (2) business days before the meeting. \nBackground material and the link to the online teleconference meeting room will be available at 2021 Meeting Materials\, Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \nFDA is establishing a docket for public comment on this meeting. The docket number is FDA-2021-N-0758. The docket will close on November 29\, 2021. Submit either electronic or written comments on this public meeting by November 29\, 2021. \nComments received on or before November 15\, 2021\, will be provided to the committee(s). Comments received after that date but by November 29\, 2021\, will be taken into consideration by FDA. \nLearn more at the FDA meeting announcement website. \n  \n 
URL:https://globalbiodefense.com/event/antimicrobial-drugs-advisory-committee-amdac-meeting/
CATEGORIES:Government Hosted
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T130000
DTEND;TZID=America/New_York:20211130T153000
DTSTAMP:20210925T002821Z
CREATED:20210925T002750Z
LAST-MODIFIED:20210925T002821Z
UID:49802-1638277200-1638286200@globalbiodefense.com
SUMMARY:Prevention and Preparedness: Webinar 3
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/prevention-and-preparedness-webinar-3/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
END:VCALENDAR